nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—hematopoietic system—hematologic cancer	0.0386	0.261	CbGeAlD
Icosapent ethyl—DGAT1—blood—hematologic cancer	0.0255	0.173	CbGeAlD
Icosapent ethyl—DGAT1—bone marrow—hematologic cancer	0.0247	0.167	CbGeAlD
Icosapent ethyl—DGAT1—lung—hematologic cancer	0.0224	0.152	CbGeAlD
Icosapent ethyl—DGAT1—testis—hematologic cancer	0.0211	0.143	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—hematologic cancer	0.0153	0.104	CbGeAlD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RARA—hematologic cancer	0.0105	0.12	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—CRABP1—hematologic cancer	0.00761	0.0871	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—FHL2—hematologic cancer	0.00335	0.0383	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—ARNTL—hematologic cancer	0.00293	0.0335	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR2—hematologic cancer	0.00281	0.0322	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.00254	0.029	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—hematologic cancer	0.00242	0.0277	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.00232	0.0266	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA3—hematologic cancer	0.00222	0.0254	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.00164	0.0187	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.00133	0.0153	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—hematologic cancer	0.00131	0.015	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CG—hematologic cancer	0.0012	0.0137	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.00117	0.0133	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PHYH—hematologic cancer	0.00113	0.0129	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FTCD—hematologic cancer	0.00113	0.0129	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GMPS—hematologic cancer	0.00113	0.0129	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.00112	0.0128	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.00107	0.0122	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CD—hematologic cancer	0.00106	0.0121	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.00105	0.0121	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SMPD3—hematologic cancer	0.00103	0.0118	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.00103	0.0118	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3R1—hematologic cancer	0.000997	0.0114	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.000964	0.011	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.00094	0.0108	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CB—hematologic cancer	0.00092	0.0105	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—B3GAT1—hematologic cancer	0.000904	0.0103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DCK—hematologic cancer	0.000904	0.0103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ASNS—hematologic cancer	0.000904	0.0103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—hematologic cancer	0.0009	0.0103	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	0.000883	0.0101	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HDC—hematologic cancer	0.000857	0.0098	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	0.000799	0.00914	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PTEN—hematologic cancer	0.000795	0.0091	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CDA—hematologic cancer	0.000784	0.00897	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PC—hematologic cancer	0.000754	0.00863	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GBA—hematologic cancer	0.000729	0.00834	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC35B2—hematologic cancer	0.000729	0.00834	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTAP—hematologic cancer	0.000666	0.00762	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—hematologic cancer	0.000613	0.00701	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—FHL2—hematologic cancer	0.000594	0.0068	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AGRN—hematologic cancer	0.000582	0.00666	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—hematologic cancer	0.000561	0.00642	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HMMR—hematologic cancer	0.000552	0.00632	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—IDH2—hematologic cancer	0.000552	0.00632	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.000521	0.00596	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ARNTL—hematologic cancer	0.000519	0.00594	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CA9—hematologic cancer	0.000505	0.00578	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ACP5—hematologic cancer	0.000505	0.00578	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOR2—hematologic cancer	0.000498	0.0057	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—IDH1—hematologic cancer	0.000475	0.00543	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TXN—hematologic cancer	0.00047	0.00537	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCC3—hematologic cancer	0.00047	0.00537	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTO1—hematologic cancer	0.00047	0.00537	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SPHK1—hematologic cancer	0.000459	0.00526	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UGT1A1—hematologic cancer	0.000441	0.00505	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CRABP1—hematologic cancer	0.000429	0.00491	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SLC22A1—hematologic cancer	0.000429	0.00491	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALOX5—hematologic cancer	0.000418	0.00479	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NUP98—hematologic cancer	0.000405	0.00464	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ADCY7—hematologic cancer	0.000393	0.0045	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOA3—hematologic cancer	0.000393	0.0045	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NUP214—hematologic cancer	0.000391	0.00447	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.000387	0.00442	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTR—hematologic cancer	0.000383	0.00438	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCG2—hematologic cancer	0.000383	0.00438	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ENO2—hematologic cancer	0.000375	0.00429	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTT1—hematologic cancer	0.000364	0.00417	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.000358	0.0041	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—SDC1—hematologic cancer	0.000356	0.00407	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.00034	0.00389	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.000336	0.00384	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.000321	0.00367	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NQO1—hematologic cancer	0.000303	0.00346	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CD44—hematologic cancer	0.000303	0.00346	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.000296	0.00339	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYCS—hematologic cancer	0.000286	0.00328	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—HSP90AA1—hematologic cancer	0.000284	0.00325	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.000256	0.00293	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTP1—hematologic cancer	0.000252	0.00289	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.000244	0.00279	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ABCB1—hematologic cancer	0.000239	0.00273	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTM1—hematologic cancer	0.000232	0.00265	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NCOR1—hematologic cancer	0.000232	0.00265	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—MTHFR—hematologic cancer	0.000205	0.00234	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	0.000181	0.00207	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CG—hematologic cancer	0.000172	0.00197	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CREBBP—hematologic cancer	0.00016	0.00183	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CD—hematologic cancer	0.000151	0.00173	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—ALB—hematologic cancer	0.000149	0.00171	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3R1—hematologic cancer	0.000143	0.00164	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CB—hematologic cancer	0.000132	0.00151	CbGpPWpGaD
Icosapent ethyl—Pruritus—Gemcitabine—hematologic cancer	0.00013	0.00017	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.00013	0.00017	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—hematologic cancer	0.00013	0.00017	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Etoposide—hematologic cancer	0.00013	0.00017	CcSEcCtD
Icosapent ethyl—Oedema—Dexamethasone—hematologic cancer	0.00013	0.000169	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Betamethasone—hematologic cancer	0.00013	0.000169	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Dexamethasone—hematologic cancer	0.00013	0.000169	CcSEcCtD
Icosapent ethyl—Oedema—Betamethasone—hematologic cancer	0.00013	0.000169	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—hematologic cancer	0.000129	0.000169	CcSEcCtD
Icosapent ethyl—Vomiting—Carmustine—hematologic cancer	0.000129	0.000169	CcSEcCtD
Icosapent ethyl—Insomnia—Triamcinolone—hematologic cancer	0.000129	0.000169	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—hematologic cancer	0.000129	0.000168	CcSEcCtD
Icosapent ethyl—Infection—Betamethasone—hematologic cancer	0.000129	0.000168	CcSEcCtD
Icosapent ethyl—Infection—Dexamethasone—hematologic cancer	0.000129	0.000168	CcSEcCtD
Icosapent ethyl—Dizziness—Vincristine—hematologic cancer	0.000128	0.000168	CcSEcCtD
Icosapent ethyl—Rash—Carmustine—hematologic cancer	0.000128	0.000168	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Prednisone—hematologic cancer	0.000128	0.000168	CcSEcCtD
Icosapent ethyl—Dermatitis—Carmustine—hematologic cancer	0.000128	0.000168	CcSEcCtD
Icosapent ethyl—Vomiting—Alitretinoin—hematologic cancer	0.000128	0.000168	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—hematologic cancer	0.000128	0.000167	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—hematologic cancer	0.000128	0.000167	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisolone—hematologic cancer	0.000128	0.000167	CcSEcCtD
Icosapent ethyl—Shock—Betamethasone—hematologic cancer	0.000127	0.000167	CcSEcCtD
Icosapent ethyl—Shock—Dexamethasone—hematologic cancer	0.000127	0.000167	CcSEcCtD
Icosapent ethyl—Dyspnoea—Triamcinolone—hematologic cancer	0.000127	0.000166	CcSEcCtD
Icosapent ethyl—Rash—Alitretinoin—hematologic cancer	0.000127	0.000166	CcSEcCtD
Icosapent ethyl—Dermatitis—Alitretinoin—hematologic cancer	0.000127	0.000166	CcSEcCtD
Icosapent ethyl—Vomiting—Ifosfamide—hematologic cancer	0.000127	0.000166	CcSEcCtD
Icosapent ethyl—Tachycardia—Dexamethasone—hematologic cancer	0.000126	0.000165	CcSEcCtD
Icosapent ethyl—Tachycardia—Betamethasone—hematologic cancer	0.000126	0.000165	CcSEcCtD
Icosapent ethyl—Dyspepsia—Triamcinolone—hematologic cancer	0.000126	0.000164	CcSEcCtD
Icosapent ethyl—Rash—Ifosfamide—hematologic cancer	0.000126	0.000164	CcSEcCtD
Icosapent ethyl—Dermatitis—Ifosfamide—hematologic cancer	0.000126	0.000164	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000125	0.000164	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Betamethasone—hematologic cancer	0.000125	0.000164	CcSEcCtD
Icosapent ethyl—Dizziness—Irinotecan—hematologic cancer	0.000125	0.000164	CcSEcCtD
Icosapent ethyl—Malaise—Prednisone—hematologic cancer	0.000125	0.000163	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—hematologic cancer	0.000124	0.000163	CcSEcCtD
Icosapent ethyl—Body temperature increased—Etoposide—hematologic cancer	0.000124	0.000163	CcSEcCtD
Icosapent ethyl—Vertigo—Prednisone—hematologic cancer	0.000124	0.000162	CcSEcCtD
Icosapent ethyl—Syncope—Prednisone—hematologic cancer	0.000124	0.000162	CcSEcCtD
Icosapent ethyl—Vomiting—Vincristine—hematologic cancer	0.000124	0.000161	CcSEcCtD
Icosapent ethyl—Anorexia—Dexamethasone—hematologic cancer	0.000123	0.000161	CcSEcCtD
Icosapent ethyl—Anorexia—Betamethasone—hematologic cancer	0.000123	0.000161	CcSEcCtD
Icosapent ethyl—Asthenia—Cisplatin—hematologic cancer	0.000123	0.000161	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—hematologic cancer	0.000123	0.000161	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—hematologic cancer	0.000123	0.00016	CcSEcCtD
Icosapent ethyl—Rash—Vincristine—hematologic cancer	0.000123	0.00016	CcSEcCtD
Icosapent ethyl—Dermatitis—Vincristine—hematologic cancer	0.000122	0.00016	CcSEcCtD
Icosapent ethyl—Pain—Triamcinolone—hematologic cancer	0.000122	0.00016	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Prednisone—hematologic cancer	0.000121	0.000159	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—hematologic cancer	0.000121	0.000158	CcSEcCtD
Icosapent ethyl—Vomiting—Irinotecan—hematologic cancer	0.00012	0.000157	CcSEcCtD
Icosapent ethyl—Vomiting—Mitoxantrone—hematologic cancer	0.00012	0.000157	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—hematologic cancer	0.00012	0.000157	CcSEcCtD
Icosapent ethyl—Hypertension—Prednisone—hematologic cancer	0.000119	0.000156	CcSEcCtD
Icosapent ethyl—Rash—Irinotecan—hematologic cancer	0.000119	0.000156	CcSEcCtD
Icosapent ethyl—Rash—Mitoxantrone—hematologic cancer	0.000119	0.000156	CcSEcCtD
Icosapent ethyl—Dermatitis—Irinotecan—hematologic cancer	0.000119	0.000156	CcSEcCtD
Icosapent ethyl—Dermatitis—Mitoxantrone—hematologic cancer	0.000119	0.000156	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—hematologic cancer	0.000119	0.000156	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000118	0.000154	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000118	0.000154	CcSEcCtD
Icosapent ethyl—Arthralgia—Prednisone—hematologic cancer	0.000118	0.000154	CcSEcCtD
Icosapent ethyl—Myalgia—Prednisone—hematologic cancer	0.000118	0.000154	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Triamcinolone—hematologic cancer	0.000118	0.000154	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—hematologic cancer	0.000117	0.000153	CcSEcCtD
Icosapent ethyl—Vomiting—Gemcitabine—hematologic cancer	0.000117	0.000153	CcSEcCtD
Icosapent ethyl—Insomnia—Dexamethasone—hematologic cancer	0.000117	0.000153	CcSEcCtD
Icosapent ethyl—Insomnia—Betamethasone—hematologic cancer	0.000117	0.000153	CcSEcCtD
Icosapent ethyl—Discomfort—Prednisone—hematologic cancer	0.000116	0.000152	CcSEcCtD
Icosapent ethyl—Rash—Gemcitabine—hematologic cancer	0.000116	0.000152	CcSEcCtD
Icosapent ethyl—Dermatitis—Gemcitabine—hematologic cancer	0.000116	0.000152	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—hematologic cancer	0.000116	0.000151	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—hematologic cancer	0.000115	0.000151	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—hematologic cancer	0.000114	0.000149	CcSEcCtD
Icosapent ethyl—Dyspepsia—Betamethasone—hematologic cancer	0.000114	0.000149	CcSEcCtD
Icosapent ethyl—Dyspepsia—Dexamethasone—hematologic cancer	0.000114	0.000149	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PTEN—hematologic cancer	0.000114	0.0013	CbGpPWpGaD
Icosapent ethyl—Dysgeusia—Methotrexate—hematologic cancer	0.000113	0.000148	CcSEcCtD
Icosapent ethyl—Asthenia—Etoposide—hematologic cancer	0.000113	0.000148	CcSEcCtD
Icosapent ethyl—Body temperature increased—Triamcinolone—hematologic cancer	0.000113	0.000148	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Prednisone—hematologic cancer	0.000113	0.000147	CcSEcCtD
Icosapent ethyl—Oedema—Prednisone—hematologic cancer	0.000113	0.000147	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dexamethasone—hematologic cancer	0.000113	0.000147	CcSEcCtD
Icosapent ethyl—Decreased appetite—Betamethasone—hematologic cancer	0.000113	0.000147	CcSEcCtD
Icosapent ethyl—Infection—Prednisone—hematologic cancer	0.000112	0.000146	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000112	0.000146	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000112	0.000146	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—hematologic cancer	0.000112	0.000146	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—hematologic cancer	0.000111	0.000146	CcSEcCtD
Icosapent ethyl—Pruritus—Etoposide—hematologic cancer	0.000111	0.000146	CcSEcCtD
Icosapent ethyl—Shock—Prednisone—hematologic cancer	0.000111	0.000145	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—hematologic cancer	0.000111	0.000145	CcSEcCtD
Icosapent ethyl—Pain—Dexamethasone—hematologic cancer	0.000111	0.000145	CcSEcCtD
Icosapent ethyl—Pain—Betamethasone—hematologic cancer	0.000111	0.000145	CcSEcCtD
Icosapent ethyl—Tachycardia—Prednisone—hematologic cancer	0.00011	0.000144	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—hematologic cancer	0.00011	0.000143	CcSEcCtD
Icosapent ethyl—Vomiting—Cisplatin—hematologic cancer	0.000109	0.000143	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Prednisone—hematologic cancer	0.000109	0.000143	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—EP300—hematologic cancer	0.000109	0.00124	CbGpPWpGaD
Icosapent ethyl—Rash—Cisplatin—hematologic cancer	0.000108	0.000142	CcSEcCtD
Icosapent ethyl—Dermatitis—Cisplatin—hematologic cancer	0.000108	0.000141	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—hematologic cancer	0.000108	0.000141	CcSEcCtD
Icosapent ethyl—Anorexia—Prednisone—hematologic cancer	0.000108	0.000141	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—hematologic cancer	0.000107	0.00014	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Betamethasone—hematologic cancer	0.000107	0.00014	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dexamethasone—hematologic cancer	0.000107	0.00014	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—hematologic cancer	0.000106	0.000138	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—hematologic cancer	0.000105	0.000137	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—hematologic cancer	0.000104	0.000136	CcSEcCtD
Icosapent ethyl—Dizziness—Etoposide—hematologic cancer	0.000104	0.000136	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—hematologic cancer	0.000104	0.000136	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—hematologic cancer	0.000103	0.000135	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000103	0.000134	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisolone—hematologic cancer	0.000103	0.000134	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—hematologic cancer	0.000103	0.000134	CcSEcCtD
Icosapent ethyl—Asthenia—Triamcinolone—hematologic cancer	0.000102	0.000134	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dexamethasone—hematologic cancer	0.000102	0.000134	CcSEcCtD
Icosapent ethyl—Body temperature increased—Betamethasone—hematologic cancer	0.000102	0.000134	CcSEcCtD
Icosapent ethyl—Insomnia—Prednisone—hematologic cancer	0.000102	0.000133	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—hematologic cancer	0.000102	0.000133	CcSEcCtD
Icosapent ethyl—Pruritus—Triamcinolone—hematologic cancer	0.000101	0.000132	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—hematologic cancer	0.000101	0.000132	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—hematologic cancer	0.0001	0.000131	CcSEcCtD
Icosapent ethyl—Vomiting—Etoposide—hematologic cancer	0.0001	0.000131	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—hematologic cancer	0.0001	0.000131	CcSEcCtD
Icosapent ethyl—Dyspepsia—Prednisone—hematologic cancer	9.93e-05	0.00013	CcSEcCtD
Icosapent ethyl—Rash—Etoposide—hematologic cancer	9.92e-05	0.00013	CcSEcCtD
Icosapent ethyl—Dermatitis—Etoposide—hematologic cancer	9.91e-05	0.00013	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—hematologic cancer	9.83e-05	0.000129	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—hematologic cancer	9.83e-05	0.000129	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—hematologic cancer	9.83e-05	0.000129	CcSEcCtD
Icosapent ethyl—Decreased appetite—Prednisone—hematologic cancer	9.81e-05	0.000128	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—hematologic cancer	9.79e-05	0.000128	CcSEcCtD
Icosapent ethyl—Rash—Prednisolone—hematologic cancer	9.79e-05	0.000128	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisolone—hematologic cancer	9.78e-05	0.000128	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—hematologic cancer	9.75e-05	0.000127	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—hematologic cancer	9.72e-05	0.000127	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—hematologic cancer	9.71e-05	0.000127	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—hematologic cancer	9.69e-05	0.000127	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—hematologic cancer	9.67e-05	0.000126	CcSEcCtD
Icosapent ethyl—Constipation—Prednisone—hematologic cancer	9.65e-05	0.000126	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—hematologic cancer	9.5e-05	0.000124	CcSEcCtD
Icosapent ethyl—Dizziness—Triamcinolone—hematologic cancer	9.44e-05	0.000123	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—hematologic cancer	9.43e-05	0.000123	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—hematologic cancer	9.43e-05	0.000123	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—hematologic cancer	9.37e-05	0.000122	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—hematologic cancer	9.33e-05	0.000122	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisone—hematologic cancer	9.3e-05	0.000122	CcSEcCtD
Icosapent ethyl—Asthenia—Dexamethasone—hematologic cancer	9.29e-05	0.000121	CcSEcCtD
Icosapent ethyl—Asthenia—Betamethasone—hematologic cancer	9.29e-05	0.000121	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—hematologic cancer	9.28e-05	0.000121	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—hematologic cancer	9.2e-05	0.00012	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—hematologic cancer	9.2e-05	0.00012	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—hematologic cancer	9.2e-05	0.00012	CcSEcCtD
Icosapent ethyl—Pruritus—Betamethasone—hematologic cancer	9.16e-05	0.00012	CcSEcCtD
Icosapent ethyl—Pruritus—Dexamethasone—hematologic cancer	9.16e-05	0.00012	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—hematologic cancer	9.11e-05	0.000119	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—hematologic cancer	9.09e-05	0.000119	CcSEcCtD
Icosapent ethyl—Vomiting—Triamcinolone—hematologic cancer	9.08e-05	0.000119	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—hematologic cancer	9.02e-05	0.000118	CcSEcCtD
Icosapent ethyl—Rash—Triamcinolone—hematologic cancer	9e-05	0.000118	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—hematologic cancer	9e-05	0.000118	CcSEcCtD
Icosapent ethyl—Dermatitis—Triamcinolone—hematologic cancer	8.99e-05	0.000118	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—hematologic cancer	8.99e-05	0.000117	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—hematologic cancer	8.99e-05	0.000117	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—hematologic cancer	8.97e-05	0.000117	CcSEcCtD
Icosapent ethyl—Body temperature increased—Prednisone—hematologic cancer	8.92e-05	0.000117	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—hematologic cancer	8.82e-05	0.000115	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—hematologic cancer	8.82e-05	0.000115	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—hematologic cancer	8.79e-05	0.000115	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—hematologic cancer	8.76e-05	0.000115	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—hematologic cancer	8.73e-05	0.000114	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—hematologic cancer	8.68e-05	0.000113	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—hematologic cancer	8.64e-05	0.000113	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—hematologic cancer	8.61e-05	0.000113	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.59e-05	0.000112	CcSEcCtD
Icosapent ethyl—Dizziness—Betamethasone—hematologic cancer	8.57e-05	0.000112	CcSEcCtD
Icosapent ethyl—Dizziness—Dexamethasone—hematologic cancer	8.57e-05	0.000112	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—hematologic cancer	8.53e-05	0.000111	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—hematologic cancer	8.53e-05	0.000111	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—hematologic cancer	8.52e-05	0.000111	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—hematologic cancer	8.52e-05	0.000111	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—hematologic cancer	8.52e-05	0.000111	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—hematologic cancer	8.41e-05	0.00011	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—hematologic cancer	8.41e-05	0.00011	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—hematologic cancer	8.4e-05	0.00011	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—hematologic cancer	8.33e-05	0.000109	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—hematologic cancer	8.3e-05	0.000108	CcSEcCtD
Icosapent ethyl—Vomiting—Dexamethasone—hematologic cancer	8.24e-05	0.000108	CcSEcCtD
Icosapent ethyl—Vomiting—Betamethasone—hematologic cancer	8.24e-05	0.000108	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—hematologic cancer	8.19e-05	0.000107	CcSEcCtD
Icosapent ethyl—Rash—Dexamethasone—hematologic cancer	8.17e-05	0.000107	CcSEcCtD
Icosapent ethyl—Rash—Betamethasone—hematologic cancer	8.17e-05	0.000107	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—hematologic cancer	8.16e-05	0.000107	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—hematologic cancer	8.16e-05	0.000107	CcSEcCtD
Icosapent ethyl—Dermatitis—Dexamethasone—hematologic cancer	8.16e-05	0.000107	CcSEcCtD
Icosapent ethyl—Dermatitis—Betamethasone—hematologic cancer	8.16e-05	0.000107	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.14e-05	0.000106	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—hematologic cancer	8.11e-05	0.000106	CcSEcCtD
Icosapent ethyl—Asthenia—Prednisone—hematologic cancer	8.09e-05	0.000106	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—hematologic cancer	8.06e-05	0.000105	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—hematologic cancer	8.04e-05	0.00092	CbGpPWpGaD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.04e-05	0.000105	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—hematologic cancer	8.03e-05	0.000105	CcSEcCtD
Icosapent ethyl—Pruritus—Prednisone—hematologic cancer	7.98e-05	0.000104	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—hematologic cancer	7.98e-05	0.000104	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—hematologic cancer	7.97e-05	0.000104	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—hematologic cancer	7.89e-05	0.000103	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—hematologic cancer	7.87e-05	0.000103	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—hematologic cancer	7.78e-05	0.000102	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—hematologic cancer	7.77e-05	0.000102	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—hematologic cancer	7.77e-05	0.000102	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—hematologic cancer	7.67e-05	0.0001	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.62e-05	9.96e-05	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—hematologic cancer	7.54e-05	9.86e-05	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—hematologic cancer	7.54e-05	9.86e-05	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisone—hematologic cancer	7.46e-05	9.75e-05	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—hematologic cancer	7.45e-05	9.74e-05	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.44e-05	9.72e-05	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—hematologic cancer	7.38e-05	9.65e-05	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—hematologic cancer	7.28e-05	9.51e-05	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—hematologic cancer	7.27e-05	9.5e-05	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—hematologic cancer	7.19e-05	9.39e-05	CcSEcCtD
Icosapent ethyl—Vomiting—Prednisone—hematologic cancer	7.17e-05	9.38e-05	CcSEcCtD
Icosapent ethyl—Rash—Prednisone—hematologic cancer	7.11e-05	9.3e-05	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisone—hematologic cancer	7.11e-05	9.29e-05	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—hematologic cancer	7.1e-05	9.28e-05	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.05e-05	9.21e-05	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—hematologic cancer	6.98e-05	9.13e-05	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—hematologic cancer	6.98e-05	9.13e-05	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—hematologic cancer	6.97e-05	9.12e-05	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—hematologic cancer	6.76e-05	8.84e-05	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—hematologic cancer	6.73e-05	8.79e-05	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—hematologic cancer	6.67e-05	8.72e-05	CcSEcCtD
Icosapent ethyl—DGAT1—Metabolism—AKT1—hematologic cancer	6.57e-05	0.000752	CbGpPWpGaD
Icosapent ethyl—Body temperature increased—Doxorubicin—hematologic cancer	6.45e-05	8.44e-05	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—hematologic cancer	6.33e-05	8.27e-05	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—hematologic cancer	6.24e-05	8.16e-05	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—hematologic cancer	6.23e-05	8.15e-05	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—hematologic cancer	5.99e-05	7.84e-05	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—hematologic cancer	5.94e-05	7.77e-05	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—hematologic cancer	5.94e-05	7.76e-05	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—hematologic cancer	5.86e-05	7.66e-05	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—hematologic cancer	5.83e-05	7.63e-05	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—hematologic cancer	5.78e-05	7.55e-05	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—hematologic cancer	5.61e-05	7.33e-05	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—hematologic cancer	5.56e-05	7.27e-05	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—hematologic cancer	5.56e-05	7.27e-05	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—hematologic cancer	5.4e-05	7.06e-05	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—hematologic cancer	5.19e-05	6.78e-05	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—hematologic cancer	5.15e-05	6.73e-05	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—hematologic cancer	5.14e-05	6.72e-05	CcSEcCtD
